Top Qs
Timeline
Chat
Perspective
Arakawa's syndrome II
Medical condition From Wikipedia, the free encyclopedia
Remove ads
Arakawa's syndrome II[2] is an autosomal dominant metabolic disorder that causes a deficiency of the enzyme tetrahydrofolate-methyltransferase; affected individuals cannot properly metabolize methylcobalamin, a type of Vitamin B12.
Remove ads
Presentation
This disorder causes neurological problems, including intellectual disability, brain atrophy and ventricular dilation, myoclonus, hypotonia, and epilepsy. [citation needed]
It is also associated with growth retardation, megaloblastic anemia, pectus excavatum, scoliosis, vomiting, diarrhea, and hepatosplenomegaly.[citation needed]
Genetics

Arakawa's syndrome II is inherited in an autosomal dominant manner. This means the defective gene responsible for disorder is located on an autosome, and one copy of the defective gene is sufficient to cause the disorder when inherited from a parent who has the disorder.[citation needed]
Diagnosis
![]() | This section is empty. You can help by adding to it. (October 2017) |
Management
![]() | This section is empty. You can help by adding to it. (October 2017) |
Eponym
It is called "Arakawa syndrome 2" after Tsuneo Arakawa (1949–2003), a Japanese Physician.;[2][3] in this context, "Arakawa syndrome 1" refers to Glutamate formiminotransferase deficiency.
References
External links
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads